A Parallel-group Active Comparator, Double-blind, Multicenter, Randomized, Double-blind, Phase III Clinical Study

NCT03936192 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Company decision

Conditions

Knee Osteoarthritis

Interventions

DRUG: glucosamine sulphate 1500mg and meloxicam 15mg
DRUG: Glucosamine sulfate 1500mg and chondroitin sulfate 1200mg
DRUG: Placebos

Sponsor

Eurofarma Laboratorios S.A.